Taysha Gene Therapies, Inc.
Biotechnology company · Dallas, Texas, United States · Nasdaq: TSHA
Taysha Gene Therapies, Inc. is a biotechnology company headquartered in Dallas, Texas, United States. Its earliest recorded incorporation is in 2019. Its shares trade on Nasdaq under the ticker TSHA. It has reported private securities offerings to the US SEC, most recently $150 million sold in a notice filed in 2023.
Taysha Gene Therapies at a glance
What does Taysha Gene Therapies do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $150 million sold (2023).
Frequently asked questions about Taysha Gene Therapies
Where is Taysha Gene Therapies headquartered?
Taysha Gene Therapies, Inc. is headquartered in Dallas, Texas, United States.
What does Taysha Gene Therapies do?
Taysha Gene Therapies, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Taysha Gene Therapies a public company?
Yes. Taysha Gene Therapies, Inc. trades on Nasdaq under the ticker TSHA.
When was Taysha Gene Therapies founded?
The earliest incorporation on record for Taysha Gene Therapies, Inc. is in 2019, according to public company registers.
Similar companies
- Spectral MD, Inc.Dallas, Texas, United States
- OncoNano Medicine, Inc.Dallas, Texas, United States
- Sonara Health, Inc.Dallas, Texas, United States
- Instil Bio, Inc.Dallas, Texas, United States
- Stingray Therapeutics, Inc.Dallas, Texas, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.